Biodexa Pharmaceuticals to Buy License to Commercialize Tolimidone for Diabetes; Shares Soar

Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.070 USD | -2.40% |
|
-7.63% | +0.49% |